On June 20, 2024, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) posted Advisory Opinion 24-04, a favorable opinion analyzing a refund and discount program designed to alleviate the financial risks…
IBRAHIM QUADRI The First Lady of Lagos State, Dr. Mrs Ibijoke Sanwo-Olu has called on corps members deployed to the State for the mandatory one year national service to make a positive impact for the growth of Lagos and Nigeria as a whole.…
An investigational medication designated TAS-303 shows efficacy and safety in treatment of women with stress urinary incontinence (SUI), reports a placebo-controlled clinical trial in the August issue of The Journal of Urology.
A multicenter safety study at UC Davis Health tested a protein drug (INBRX-101), developed to improve care for people with alpha-1 antitrypsin deficiency (AATD), and showed the therapy is quite safe.
The Nigerian Correctional Service (NCoS), FCT command Wednesday apprehended a lady, Precious Yusuf, trying to push drug to inmates of medium Security Custodial Centre, Kuje, Abuja. This was contained in …
The Psychiatry and Mental Health research group at the Germans Trias i Pujol Research Institute (IGTP), together with the ETEP (Study and Treatment of Psychotic Episodes) group at Hospital del Mar, has published a study in the Spanish…
Shares of Eli Lilly and Co (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) finished lower on Thursday, perhaps influenced by competitive developments and regulatory updates in the pharmaceutical sector.
On June 5, ALERT said Calgary's organized crime team executed a search warrant at a home in the northeast community of Harvest Hills, along with two vehicles.
The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on drug prices due to market consolidation. This trend raises critical questions about the future of the cannabis…
Enveric Biosciences has been granted a U.S. patent for EB-002, enhancing protection for treatments targeting brain neurological disorders, including depression and anxiety.
The FDA recently approved the anti-amyloid drug donanemab, sold as Kisunla. The medication can delay cognitive decline in early Alzheimer's patients by about seven months, but it is expensive and can have serious side effects. Still, it…